VTVT: vTv Therapeutics Company Value to Net Income

Symbol and logo of brand vTv Therapeutics (VTVT)

The price chart for vTv Therapeutics Inc. (VTVT) highlights the risks: global conflicts and sanctions are undermining component logistics and closing access to external markets. Meanwhile, vTv Therapeutics Inc. (VTVT) is developing oral treatments for type 1 diabetes, whose patent protection guarantees multi-year revenue at the level of -9.20. The production cycle relies on external contractors with optimized workflows, which completely eliminates the risk of capacity shutdowns.

P/E Multiple: vTv Therapeutics, Inc. (VTVT) for 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for vTv Therapeutics Inc (VTVT)

- price and consensus price forecast:
Summary company analysis:vTv Therapeutics, Inc.
Finished products of vTv Therapeutics, Inc.

The development of oral therapies for chronic metabolic diseases expands the market reach of vTv Therapeutics Inc. (VTVT), mitigating specific pharmaceutical sector risks. By analyzing the company's P/E time series, an investor assesses the ratio of market capitalization to net income, which allows for determining the premium paid for future rates of return on investment and confirming the fundamental stability of current quotes.